Physician profile
Samer Obri
NPI 1700879657
$5,787.66
in general payments reported to CMS, 2019-2025
41 companies · $845 in 2025
The $845 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $162 · 2021: $217 · 2022: $815 · 2023: $849 · 2024: $1,299 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,993.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $977.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $507.88 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $483.58 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $471.48 | 2019-2022 | |
| Abbvie INC. | $469.94 | 2022-2025 | |
| Amgen INC. | $408.37 | 2019-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $288.10 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.54 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $196.98 | 2022-2024 | |
| Inari Medical, INC. | $191.52 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $186.02 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $164.99 | 2019-2024 | |
| Glaxosmithkline, LLC. | $152.99 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $142.28 | 2019-2025 | Mounjaro, Jardiance |
| Sunovion Pharmaceuticals INC. | $124.62 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Obri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.